The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study
Hijiya N et al. Blood Adv, Sept 2023 (epub ahead of print)
The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study
Hijiya N et al. Blood Adv, Sept 2023 (epub ahead of print)